ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT

被引：0
|
作者：
Goncalves, Ivone M. [1 ]
Monteiro, Regina [1 ]
Neves, Sofia [1 ]
Conde, Sara [1 ]
Campainha, Sergio [1 ]
Parente, Barbara [1 ]
机构：
[1] Espinho Epe, Ctr Hosp Vila Nova De Gaia, Oporto, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
erlotinib; Non-small cell lung cancer; EGFR; mutational status;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1298 / S1298
页数：1
相关论文
共 50 条
  • [1] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
  • [2] Cutaneous toxicity in erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Bernabee, R.
    Cobo, M.
    Barneto, I.
    Valdivia, J.
    Fernandez, I.
    Rueda, A.
    Villatoro, R.
    de la Curz, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [4] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    [J]. DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [5] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    [J]. BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [6] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [7] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Reck, M.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
  • [8] Rational selection of biomarkers to help direct erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Borgia, Jeffrey A.
    Frankenberger, Casey
    Basu, Sanjib
    Rouhi, Omid
    Fidler, Mary J.
    Batus, Marta
    Fhied, Cristina L.
    Dalovisio, Andrew P.
    Lie, Wen-Rong
    Maheshwari, Reeti
    Hayes, David
    Coon, John
    Bonomi, Philip
    [J]. CANCER RESEARCH, 2011, 71
  • [9] COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ROMANIA
    Ciuleanu, T. E.
    Dediu, M.
    Minea, L. N.
    Baculea, S.
    Szkultecka-Debek, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A38 - A38
  • [10] Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
    Wang, Yongsheng
    Schmid-Bindert, Gerald
    Zhou, Caicun
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (01) : 19 - 29
12345